摘要
目的:研究四环素调控系统对DT390-VEGF165融合基因在人胃癌细胞中表达的影响。方法:构建四环素调控的DT390-VEGF165融合基因真核表达载体,用脂质体介导转染胃癌细胞SGC7901,在四环素有或无的情况下检测胃癌细胞的存活率。结果:4μg构建物转染5×105个胃癌细胞/孔(24孔板)96h后发现,无四环素时转毒素融合基因的细胞的存活率为20%;四环素存在时转毒素融合基因的细胞的存活率为66%;转染细胞在四环素有或无的情况下经白喉抗毒素-FITC免疫荧光抗体染色均呈现黄绿色荧光,表明融合基因在细胞中得到了表达,且四环素调控系统存在基础量的漏表达。结论:四环素调控系统基本上可以控制毒素基因在人胃癌细胞中的表达。
Objective: To study the influence of tetracycline-controlled system on expression of the DT390-VEGF165 fusion gene in human gastric carcinoma cell. Methods: The eukaryotic expression vectors containing DT390-VEGF165 gene under transcriptional c ontrol of a tetracycline-controlled system were constructed. 4μg of constructs were introduced into SGC7901 cells (5×105 cells/well, 24 well) by means of lipofectamine-mediated gene transfer procedure. The transfected cellular morphology was observed bo th in the absence and in the presence of tetracycline. Results: It was shown that virtually 80% SGC7901 cells were killed in the activated state(i.e. without tetracycline), 66% cells were survived in the repressed state(i.e. with tetracycline), whereas a n undesirable leakage of expression occurred in the repressed state. Immunohistochemistry showed the transfected cells with or without tetracycline could be stained by anti-DT-FITC, indicating the chimeric gene expression in SGC7901 cell. Conclusions: Th e chimeric gene can be controlled by tetracycline-controlled system and result in cellular toxicity in the absence of tetracycline.
出处
《外科理论与实践》
2001年第3期174-175,共2页
Journal of Surgery Concepts & Practice
基金
国家自然科学基金(39770834)